Revenue: The sum of all revenue fields included for a company's operating activities.
Panacea Life Sciences Holdings, Inc. (PLSH) had Revenue of $2.38M for the most recently reported fiscal year, ending 2023-12-31.
Income Statement Financials | |
Revenue |
$2.38M |
$-8.02M |
|
$1.26M |
|
$1.12M |
|
$7.93M |
|
$-5.55M |
|
$-2.47M |
|
$-8.02M |
|
$-6.92M |
|
$-8.02M |
|
$-8.02M |
|
$-8.02M |
|
$-6.92M |
|
$-5.55M |
|
$-3.79M |
|
16.63M |
|
16.63M |
|
$-0.48 |
|
$-0.48 |
|
Balance Sheet Financials | |
$4.66M |
|
$6.45M |
|
$13.33M |
|
$17.98M |
|
$19.45M |
|
-- |
|
$6.83M |
|
$26.27M |
|
$-8.29M |
|
$-11.31M |
|
$-8.29M |
|
17.64M |
|
Cash Flow Statement Financials | |
$-1.52M |
|
$-0.07M |
|
$1.68M |
|
$0.01M |
|
$0.10M |
|
$0.09M |
|
-- |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
0.24 |
|
-- |
|
-- |
|
-- |
|
-1.42 |
|
47.04% |
|
-232.55% |
|
-232.55% |
|
-159.12% |
|
-336.08% |
|
-336.08% |
|
$-1.52M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.31 |
|
9.04 |
|
40.40 |
|
96.66% |
|
70.89% |
|
-44.57% |
|
96.67% |
|
$-0.47 |
|
$-0.09 |
|
$-0.09 |